MotiNRamgopalMDFACP FIDSA
Infectious Disease • Fort Pierce, FLConsultant Physician /Director Associates in Infectious Disease Director/Founder Midway Immunology and Research Center Asst.Professor Medicine Florida State University Medical School
Dr. Ramgopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
356 E Midway Rd
Fort Pierce, FL 34982Phone+1 772-464-9746Fax+1 772-464-9750
Summary
- Dr. Moti Ramgopal is an infectious disease specialist in Fort Pierce, FL and is affiliated with multiple hospitals in the area, including Lawnwood Regional Medical Center & Heart Institute, Port St. Lucie Hospital, and St. Lucie Medical Center. He received his medical degree from University of the West Indies Faculty of Medical Sciences and has been in practice 28 years. He is experienced in travel and tropical medicine, infectious disease, osteomyelitis, prevertebral infection, and mandibular space infection.
Education & Training
University of Miami/Jackson Health SystemFellowship, Infectious Disease, 1995 - 1997
Bon Secours HospitalResidency, Internal Medicine, 1992 - 1995
University of the West Indies Faculty of Medical SciencesClass of 1989
Certifications & Licensure
FL State Medical License 1996 - 2026
MI State Medical License 1994 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 2 citationsDEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain.David Anderson, Moti Ramgopal, Debbie P Hagins, Johnnie Lee, Richard Bruce Simonson
Clinical Infectious Diseases. 2025-03-17 - 4 citationsEfficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.Onyema Ogbuagu, Jean-Michel Molina, Ploenchan Chetchotisakd, Moti N Ramgopal, William Sanchez
Clinical Infectious Diseases. 2025-03-17 - Participant-reported Outcomes from the CAPELLA Clinical Trial of Lenacapavir-based Regimens in Heavily Treatment-experienced Adults with HIV.Moti Ramgopal, Dylan J Mezzio, Keith Dunn, Shan-Yu Liu, Damemarie Paul
AIDS and Behavior. 2025-03-10
Press Mentions
COVID Surge: What if We Had Just Listened to Local Doctors Pierone, Ramgopal? | OpinionAugust 6th, 2021- The Science of COVID-19: COVID-19 and Treatment of AdultsMarch 8th, 2021
- Doctor Says We Need to Be One Step Ahead of the VariantFebruary 16th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
